Company Filing History:
Years Active: 2002-2010
Title: The Innovative Contributions of Stephen Rundlett
Introduction
Stephen Rundlett is a notable inventor based in Chagrin Falls, Ohio. He has made significant contributions to the field of gene expression and biotechnology, holding a total of 13 patents. His work focuses on innovative methods for activating endogenous genes, which have implications for understanding human diseases and development.
Latest Patents
Rundlett's latest patents include compositions and methods for non-targeted activation of endogenous genes. This invention is directed towards activating gene expression or causing over-expression of a gene through recombination methods in situ. The invention outlines methods for expressing an endogenous gene in a cell at levels higher than those typically found. One embodiment involves the activation of an endogenous gene following the integration of a regulatory sequence that enhances gene expression. Additionally, the invention allows for the identification, activation, isolation, and expression of genes that are not discoverable by current methods, as it does not require a target sequence for integration. This advancement enables the activation and isolation of endogenous genes associated with human disease and development without prior knowledge of their sequence or function.
Career Highlights
Throughout his career, Stephen Rundlett has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Athersys, Inc. and Abt Holding Company. His experience in these organizations has contributed to his expertise in gene expression technologies and innovative research methodologies.
Collaborations